Mouse α-fetoprotein-specific DNA-based immunotherapy of hepatocellular carcinoma leads to tumor regression mice

Gastroenterology

Volumn 119, Issue 4, 2000, Pages 1104-1112

  Grimm, Christian F ^a   Ortmann, Darte ^a   Mohr, Leonhard ^a   Michalak, Sabine ^a   Krohne, Tim U ^a   Meckel, Stephan ^a   Eisele, Silke ^a   Encke, Jens ^b   Blum, Hubert E ^a   Geissler, Michael ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; ALPHA FETOPROTEIN ANTIBODY; CYTOKINE; DNA VACCINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; INTERLEUKIN 18; PLASMID DNA; TUMOR ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EXPRESSION VECTOR; FEMALE; GENE GUN; LIVER CELL CARCINOMA; LIVER CELL DAMAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL TIME; TUMOR MODEL; TUMOR REGRESSION; VACCINIA VIRUS; VIRUS RECOMBINANT;

EID: 0033769892     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2000.18157     Document Type: Article

References (26)

1. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients
2. Genetic immunization is a simple method for eliciting an immune response
3. Direct gene transfer into mouse muscle in vivo
4. Hepatocellular carcinoma
5. Human tumor antigens recognized by T lymphocytes
6. Cryptic epitopes on alpha-fetoprotein induce spontaneous immune responses in hepatocellular carcinoma, liver cirrhosis, and chronic hepatitis patients
7. Generation of human T-cell responses to an HLA-A2.1-restricted peptide epitope derived from alpha-fetoprotein
8. Enhancement of cellular and humoral immune responses to hepatitis C virus (HCV) core protein using DNA based vaccines augmented with cytokine expressing plasmids
9. Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines
10. Vaccinia virus: A tool for research and vaccine development
11. Ongoing T1 or T2 immune responses to the hepatitis B surface antigen (HBsAg) are excluded from the liver of mice in which transgene-encoded HBsAg is expressed
12. + T cell dependent
13. DNA vaccination primes MHC class I-restricted. Simian virus 40 large tumor antigen-specific CTL in H-2d mice that reject syngeneic tumors
14. Protective immunization against melanoma by gp100 DNA-HVJ-liposome vaccine
15. Tumor immunity and autoimmunity induced by immunization with homologous DNA
16. gp100/pmel 17 Is a murine tumor rejection antigen: Induction of 'self'-reactive, tumoricidal T cells using high-affinity, altered peptide ligand
17. Positive selection of extrathymically developed T cells by self-antigens
18. The evolution of self-tolerance: A new cell arises to meet the challenge of self-reactivity
19. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes
20. Breaking tolerance leads to autoantibody production but not autoimmune liver disease in hepatitis B virus envelope transgenic mice
21. Failure to induce organ-specific autoimmunity by breaking of tolerance: Importance of the microenvironment
22. Alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma
23. The inhibitory effects of chronic ethanol consumption on cellular immune responses to hepatitis C virus core protein is reversed by genetic immunizations augmented with cytokine expressing plasmids
24. Cellular and humoral immune response to hepatitis B virus structural proteins in mice after DNA-based immunization
25. Intracellular retention of hepatitis B virus surface proteins reduces the immune response augmenting effects of IL-2 after cytokine genetic coimmunizations
26. + T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity